Difference between revisions of "Template:Dopamine receptor modulators"
Jump to navigation
Jump to search
imported>Colonies Chris (minor fixes) |
imported>Medgirl131 |
||
| Line 128: | Line 128: | ||
* [[Dihydroergocryptine]] | * [[Dihydroergocryptine]] | ||
* [[Epicriptine]] | * [[Epicriptine]] | ||
| + | * [[Ergocornine]] | ||
* [[Lisuride]] | * [[Lisuride]] | ||
* [[Lysergic acid diethylamide|LSD]] | * [[Lysergic acid diethylamide|LSD]] | ||
| Line 335: | Line 336: | ||
* ''Others'': [[3-PPP]] | * ''Others'': [[3-PPP]] | ||
| + | * [[Alpiropride]] | ||
* [[Azapride]]<!--Irreversible--> | * [[Azapride]]<!--Irreversible--> | ||
* [[Buspirone]] | * [[Buspirone]] | ||
Revision as of 15:04, 24 December 2017
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Dopamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Dopamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Dopamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.